Abstract
In a woman’s life, a remarkable event occurs when she is approximately 50 years old, now as well as a century ago when longevity was much shorter: ovulation stops, and therefore fertility. Consequently, estradiol, the archetypal estrogen, decreases to a very low level in the blood — lower (naturally in absence of replacement administration) than it is in men and even aging men (Table 1). In women, hormone replacement therapy, mainly with estrogen, produces recognized benefits for several estrogen deficit-associated physical impairments. In the twentieth century, the discoveries of sex hormones, of their main mechanism of action at the gene expression level via nuclear receptors, and of the synthesis of synthetic active derivatives and preparations permitting relatively easy utilization (including specific estrogen receptor modulators (SERMs), have had many positive effects on the lives of menopausal and postmenopausal women.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Tenover JS, McLachlan RI, Dahl KD, Burger HG, de Kretser DM, Bremner WJ. Decreased serum inhibin levels in normal elderly men: Evidence for a decline in Sertoli cell function with aging. J Clin Endocrinol Metab 1988;67:455–59.
Vermeulen A, Deslypere JP. Testicular endocrine function in the ageing male. Maturitas 1985;7:273–79.
Nieschlag E, Lammers U, Freischem CW, Langer K, Wickings EJ. Reproductive functions in young fathers and grandfathers. J Clin Endocrinol Metab 1982;55:676–81.
Bauer J. The male climacteric: A misnomer. JAMA Dec. 2, 1944, Correspondence.
McKinlay JB, Longcope C, Gray A. The questionable physiologic and epidemiologic basis for a male climacteric syndrome: Preliminary results from the Massachusetts Male Aging Study. Maturitas 1989:11:103–15.
Werner AA. The male climacteric. JAMA 1946; 132:188–94.
Vermeulen A, Goemaere S, Kaufman JM. Sex hormones, body composition and aging. The Aging Male 1999;2:8–15.
Morley JE, Kaiser FE, Perry HL III, et al. Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism 1997;46: 410–13.
Morley JE, Kaiser FE, Raum, WJ, et al. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: Progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ration of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 1997;94:7537–42.
Veldhuis JD, Urban RJ, Lizarralde G, Johnson ML, Iranmanesh A. Attenuation of luteinizing hormone secretory burst amplitude as a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 1992;75:707–13.
Winters SJ, Troen P. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: Evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol Metab 1982;55:560–65.
Bremner WJ, Vitiello MV, Prinz PN. Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 1983;56:1278–81.
Seidman SN, Walsh BT. Testosterone and depression in aging men. Am J Geriatr Psychiatry 1999;7:18–33.
Heinemann LAJ, Zimmermann T, Vermeulen A, Thiel C, Hummel W. A new “aging males’ symptoms” rating scale. The Aging Male 1999;2:105–14.
Mercier-Bodard C, Alfsen A, Baulieu EE. Sex steroid binding plasma protein (SBP). Acta Endocrinologica 1970;64:204–24.
Tremblay RR, Masse J. Usefulness and limitation of bioavailable testosterone in assessment of androgenicity during the process of aging in men. The Aging Male 1999;2:16–21.
Vermeulen A, Kaufman JM, Giagulli VA. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab 1996;81:1821–26.
Baulieu EE, Mauvais-Jarvis P. Studies on testosterone metabolism. I Conversion of testosterone-17α3H to 5α and 5β androstane-3α, 17βdiol-17α3H: A new “17β-hydroxyl pathway.” J Biol Chem 1964;239:1569–77.
Krithivas K, Yurgalevitch SM, Mohr BA, et al. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 1999;162:137–42.
Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984;17:1051–62.
Legrain S, Massien C, Lahlou N, et al. Dehydroepiandrosterone replacement administration: Pharmacokinetic and pharmacodynamic studies in healthy elderly subjects. J Clin Endocrinol Metab 2000;85:3208–17.
Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: Contribution of the DHEAge Study to a sociobiomedical issue. Proc Natl Acad Sci USA 2000;97:4279–84.
Janowsky JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behav Neurosci 1994;108:325–32.
Rubinow DR, Schmidt PJ. Androgens, brain, and behavior. Am J Psychiatry 1996; 153: 974–84.
Sternbach H. Age-associated testosterone decline in men: Clinical issues for psychiatry. Am J Psychiatry 1998;155:1310–18.
Barrett-Connor E, von Mühlen DG, Kritz-Silverstein D. Bioavailable testosterone and depressed mood in older men: The Rancho Bernardo study. J Clin Endocrinol Metab 1999: 84:573–77.
Wolkowitz OM, Reus VI, Roberts E, et al. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry 1997;41:311–18.
Morley JE. Erectile dysfunction in senescence: Treatment options. In: M. Filicori, editor. Endocrine basis of reproductive function. Bologna, Italy: Monduzzi Editori, 2000; 537–50.
Behre HM, Nieschlag E. Testosterone treatment and the prostate. In: M. Filicori, editor. Endocrine basis of reproductive function. Bologna, Italy: Monduzzi Editori, 2000:579–86.
Bardin CW, Swerdloff RS, Santen RJ. Androgens: Risks and benefits. J Clin Endocrinol Metab 1991;73:4–7.
Cummings DE, Kumar N, Bardin C W, Sundaram K, Bremner WJ. Prostate-sparing effects in primates of the potent androgen 7α-methyl-19-nortestosterone: A potential alternative to testosterone for androgen replacement and male contraception. J Clin Endocrinol Metab 1998;83:4212–19.
Vanderschueren D, Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R. An aged rat model of partial androgen deficiency: Prevention of both loss of bone and lean body mass by low-dose androgen replacement. Endocrinology 2000;141:1642–47.
Kudlacek S, Resch H, Pietschmann P, Willvonseder R. Hormones and osteoporosis in theaging male. The Aging Male 1999;2:145–50.
Baumgartner RN, Waters DL, Gallagher D, Morley JE, Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mechanisms of Ageing and Development 1998; 107:123–36.
Crook D. Androgen therapies and the risk of cardiovascular disease. In: M. Filicori, editor. Endocrine basis of reproductive function. Bologna, Italy: Monduzzi Editori, 2000;569–77.
Phillips GB, Pinkernell BH, Jing T-Y. The association of hypotestosteronemia with coronary artery disease in men. Arterioscler Thromb 1994;14:701–6.
Lunenfeld B. Hormone replacement therapy in the aging male. The Aging Male 1999;2:1 -5.
Snyder PJ, Peachey H, Hannoush P, et al. Treatment of elderly men with testosterone. In: M. Filicori, editor. Endocrine basis of reproductive function. 2000;587–605.
Tenover JS. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992;75:1092–98.
Sih R, Morley JE, Kaiser FE, Perry HM III, Patrick P, Ross C. Testosterone replacement in older hypogonadal men: A 12-month randomized controlled trial. J Clin Endocrinol Metab 1997;82:1661–67.
Vermeulen, A. The future of hormone replacement therapy in the aging male. The Aging Male 2000;3:210–13.
Mazat L, Lafont S, Berr C, et al. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc Natl Acad Sci USA 2001;98:8145–50.
Yen SCC. Dehydroepiandrosterone sulfate and longevity: New clues for an old friend. Commentary. Proc Natl Acad Sci USA 2001;98:8167–69.
Marin P, Arver S. Androgens and abdominal obesity. Baillières Clin Endocrinol Metab 1998;12:441–51.
Gooren LJG. Male reproductive health: What are the issues? In: M. Filicori, editor. Endocrine basis of reproductive function. Bologna, Italy: Monduzzi Editori, 2000;491–524.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Baulieu, EE. (2002). Andropause at the Beginning of the New Century: A Few Remarks on Hormones and Aging of Men. In: Lobo, R.A., Crosignani, P.G., Paoletti, R., Bruschi, F. (eds) Women’s Health and Menopause. Medical Science Symposia Series, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-1061-1_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-1061-1_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5375-1
Online ISBN: 978-1-4615-1061-1
eBook Packages: Springer Book Archive